Global Sleep Apnea Devices Market Outlook, 2028

Sleep apnea is a common yet often undiagnosed sleep disorder that affects millions of people worldwide. Characterized by pauses in breathing or shallow breaths during sleep, sleep apnea can have serious implications for overall health and well-being. Sleep apnea is a prevalent sleep disorder affecting millions of people worldwide, characterized by interrupted breathing during sleep. According to the National Sleep Foundation, 50-70 million people have ongoing sleep disorders, let alone in US. The most common sleep disorder is insomnia, which involves difficulty falling or staying asleep. Fortunately, advancements in medical technology have led to the development of various devices aimed at managing and treating sleep apnea. The sleep apnea devices industry has witnessed remarkable growth in recent years, driven by increasing awareness of sleep apnea, advancements in technology, and a growing understanding of the importance of quality sleep for overall health.

As awareness of sleep apnea grows, so does the demand for effective solutions to improve sleep quality and overall well-being. The consumer landscape for sleep apnea devices reflects a diverse array of preferences, needs, and expectations. An increasing awareness of sleep apnea has empowered consumers to seek information about available devices. Consumers are more likely to make informed decisions when equipped with knowledge about the types of devices, their functionalities, and their potential benefits. The digital age has facilitated easy access to information. Consumers often turn to online platforms, forums, and reputable health websites to gather insights, read reviews, and educate themselves about sleep apnea devices before making a purchase. The comfort of the mask is a critical consideration for consumers using Positive Airway Pressure (PAP) devices.

Manufacturers have responded by designing masks with various shapes, sizes, and materials to enhance user comfort and reduce feelings of claustrophobia. Consumer preferences also lean towards quieter devices. Manufacturers strive to develop sleep apnea devices with reduced noise levels, addressing a common concern for individuals who share sleeping spaces with partners. The consumer landscape reflects a growing preference for portable and travel-friendly sleep apnea devices. Compact designs and lightweight materials cater to the needs of individuals who lead active lifestyles or frequently travel. Consumers like devices that seamlessly integrate into the daily routine, requiring minimal adjustment and maintenance. This integration enhances compliance and contributes to the effectiveness of treatment.

According to the research report, “Global Sleep Apnea Devices Market Outlook, 2028”, the market is anticipated to cross USD 12 Billion by 2028, increasing from USD 8.47 Billion in 2022. The market is expected to grow with more than 7% CAGR by 2023-28. The increasing prevalence of sleep apnea, an increase in the geriatric population, an increase in the prevalence of obesity and hypertension, and increased awareness among the patient population in emerging nations are the primary drivers driving the market. Aging is a major element driving the growth of the sleep apnea device market. The elderly are particularly vulnerable to getting this illness.

Furthermore, it was revealed that sleep disturbances are among the most difficult medical conditions to treat, affecting one out of every three persons at some point in their life. Sleep apnea is a potentially fatal sleep disorder that often goes misdiagnosed and untreated. Various government programs, however, are assisting OSA patients.

In the United States, for example, the American Sleep Apnea Association (ASAA) is a non-profit organization that raises awareness of sleep apnea, strives to improve treatment, and fights for the interests of sleep apnea patients. In addition, manufacturers' increased product releases to fulfill the growing demand for innovative goods are likely to boost market growth. In August 2021, for example, ResMed announced a new sleep apnea machine in an attempt to fill the hole left by Philips' CPAP recall. Similarly, GoPAPfree, a homecare provider of oral appliance therapy for obstructive sleep apnea, unveiled O2Vent Optima in February 2021, a highly effective and more convenient alternative to CPAP therapy. Furthermore, numerous government organizations, including the American Sleep Association and the German Sleep Society, are launching awareness campaigns to improve the quality of life for persons suffering from complicated and chronic sleep disorders.

The desire for early-stage diagnosis is likely to drive market revenue as consumers get more information about sleep problems and their health effects. Chronic insomnia is becoming more common as the number of older and obese persons grows. Furthermore, the growing number of individuals suffering from melancholy, chronic sickness, and anxiety is driving up demand for sleep apnea equipment. Furthermore, the development of such devices would aid in the targeting of high-insomnia burden areas in underdeveloped countries.

Based on the region, North America currently dominates the market for sleep apnea devices, and it is expected to continue during the forecast period.

Changing lifestyles, greater disposable income, the existence of well-known players, an obese population, an increase in the frequency of respiratory disorders, increased awareness of OSA, and favorable government initiatives are among the primary reasons driving growth. Philips Respironics, Somnetics International Inc., and ResMed are among the leading players in North America. These companies have a significant commercial presence and well-established supply and distribution systems throughout North America. The rising prevalence of sleep apnea due to many underlying disorders such as sadness and anxiety, technological improvements, and research-increasing product introductions, as well as the significant influence of COVID-19 lockdowns on Americans in the region, are expected to drive the market.

Furthermore, the increasing prevalence of other health issues, including as obesity and heart disease, which are high-risk factors for sleep apnea, is predicted to contribute to market growth. Furthermore, various government agencies are launching public awareness campaigns to educate consumers and medical professionals about healthy sleeping habits. Furthermore, the market's leading players are investing heavily in the development of technologically efficient, effective, and simple-to-use gadgets. It has been found that changes in lifestyle habits frequently result in a variety of sleeping difficulties. Furthermore, increased consumption of tobacco, caffeine, and alcohol has an impact on an individual's sleep pattern. Furthermore, the increase in the number of sleep care centers in the region is likely to drive market expansion.

GoPAPfree, for example, announced the launch of its new individualized oral appliance treatment equipment on February 9, 2021, which provides an efficient and acceptable alternative to CPAP therapy for obstructive sleep apnea with at-home shaping and implementation. The presence of various centers in North America, such as Carilion Clinic, Adam Moscovitch, Florida Lung, Asthma, and Sleep Specialists, Oregon Sleep Associates, and Sound Sleep Health, will further boost the region's growth.

On the basis of product types, the therapeutic devices segment is the highest contributor to the market and is expected to grow at a significant growth rate during the forecast period.

During the projected period, the therapeutic devices segment is expected to account for the majority of revenue. This is due to an increase in the number of patients seeking treatment in sleep clinics, including CPAP therapy, as well as the development of new digital technologies aimed at making therapy setup and night usage easier for patients while also assisting physicians in providing care more effectively. For example, on August 16, 2021, ResMed, a global innovator in digital health and sleep apnea treatment, launched AirSense 11, the company's next-generation Positive Airway Pressure (PAP) device designed to assist hundreds of millions of sleep apnea patients worldwide in establishing and maintaining treatment for managing and treating obstructive sleep apnea. The presence of a large undiagnosed population, as well as increased awareness among these patients, is resulting in higher diagnosis rates in both developed and developing countries.

This is increasing demand in these countries for diagnostic devices like as polysomnography devices. Therapeutic devices include positive airway pressure (PAP) devices, oral devices, nasal devices, and chin straps. The therapeutic devices category dominated the whole market in terms of revenue share in 2019. Manufacturers of SA devices should expect profitable possibilities as a result of factors such as greater patient adherence to supportive treatment, increased availability of technologically improved equipment, an increase in the number of efforts by local governments, and increased awareness of these diseases.

This is expected to boost expansion in the therapeutic devices category throughout the forecast period. However, due to the increasing prevalence of sleep apnea mask comorbidities and the increased use of Continuous Positive Airway Pressure (CPAP) machines for illness management, the use of sleep apnea masks is expanding.

There are a variety of SA masks available, including nasal masks, nasal pillow masks, and full-face masks. Continuous Positive Airway Pressure (CPAP) masks are used to connect the SA patient to the CPAP machine. Every CPAP mask works in the same way, delivering air from the CPAP machine to the patient's airway via a hose. This avoids Obstructive Sleep Apnea by keeping the airway open during sleeping. The use of sleep apnea masks is expected to be influenced by technological developments in sleep apnea devices.

The home care settings & individuals segment is expected to dominate the global market by 2028 propelled by the accelerating adoption and introduction of user-friendly homecare sleep apnea devices, along with spreading awareness associated with home healthcare.

During the projected period, the increased usage of sleep apnea diagnostic and treatment devices for self-administration in home care settings is expected to boost the growth of this market segment. Home care sleep diagnostic technology is accurate for people with mild to severe sleep apnea. They are considered less obtrusive because they are utilized in a typical household atmosphere. Market suppliers are investing in the development of technologies for home sleep apnea diagnostics. Due to increased investments by leading market players, the home care settings/individuals sector is likely to gain a greater revenue share during the forecast period. For example, on October 3, 2022, Acurable, a UK-based medical device company, announced a USD 10.8 million Series A fundraising round headed by Kibo Ventures. The fund was co-led by Mundi Ventures, Comprador Holdings, and Kindred Capital.

This financing will be used to accelerate the international expansion of AcuPebble SA100, the company's first home sleep-testing device for detecting and monitoring obstructive sleep apnea. Market participants are concentrating their efforts on introducing novel and portable gadgets for home usage among patients getting treatment for the illness. This, combined with an increased preference for home-based treatment of OSA, particularly in nations such as the United States, the United Kingdom, Germany, and Japan, is driving up demand for these devices in homecare and other settings. For example, GoPAPfree, a homecare provider of oral appliance therapy for sleep apnea, launched O2Vent OptimaI in February 2021, which is a highly effective and alternative therapy to CPAP therapy that can be utilized at home. This, together with sufficient reimbursement regulations that promote home usage of these devices, is further facilitating market expansion.

Market Drivers

• Increasing Prevalence of Sleep Apnea: The rising prevalence of sleep apnea worldwide is a significant driver for the sleep apnea devices market. Factors such as obesity, sedentary lifestyles, and an aging population contribute to the growing incidence of sleep apnea. As awareness of sleep disorders increases among both healthcare professionals and the general population, the demand for diagnostic and therapeutic devices for sleep apnea is expected to rise.
• Technological Advancements in Sleep Apnea Devices: Advances in technology have led to the development of more efficient and user-friendly sleep apnea devices. Innovations in device design, such as the use of compact and wearable devices, improved mask technologies, and the incorporation of data connectivity for remote monitoring, contribute to better patient compliance and treatment outcomes. Technological advancements are likely to drive market growth as healthcare providers seek more effective and patient-friendly solutions.

Market Challenges

• Limited Patient Compliance: Continuous Positive Airway Pressure (CPAP) therapy, which is a common treatment for sleep apnea, may be perceived as uncomfortable by some patients, leading to poor adherence. Addressing issues related to patient comfort, education, and support is crucial to improving compliance rates and ensuring the effectiveness of sleep apnea treatments.
• High Cost of Sleep Apnea Devices: The cost of sleep apnea devices, particularly advanced devices with sophisticated features, can be a barrier to widespread adoption. Affordability is a significant concern, particularly in regions with limited healthcare resources. Manufacturers and healthcare providers face the challenge of balancing the development of advanced technologies with the need to make these devices accessible and cost-effective for a broader patient population.

Market Trends

• Home Sleep Testing (HST): There is a growing trend toward home sleep testing as an alternative to traditional in-laboratory sleep studies. Home sleep testing allows for more convenient and cost-effective diagnosis of sleep apnea, contributing to increased patient access to testing. This trend aligns with the broader movement towards decentralized healthcare and patient-centric solutions.
• Integration of Artificial Intelligence (AI) and Data Analytics: The integration of AI and data analytics in sleep apnea devices is a notable trend. Smart devices can collect and analyze data related to sleep patterns and treatment adherence, providing valuable insights for both patients and healthcare providers. AI algorithms can enhance the personalization of treatment plans, leading to more effective interventions and improved patient outcomes.
• Telemedicine and Remote Monitoring: The trend toward telemedicine and remote patient monitoring has been accelerated, especially in the context of sleep apnea. Telemedicine allows for virtual consultations, remote monitoring of sleep patterns, and adjustments to treatment plans without the need for frequent in-person visits. This trend has become more prominent, particularly in situations where access to healthcare facilities is challenging.

COVID-19 Impact

The pandemic has disrupted global supply chains, affecting the manufacturing and distribution of medical devices, including sleep apnea devices. Lockdowns, travel restrictions, and changes in demand for healthcare resources have led to challenges in the production and delivery of these devices. Due to the pandemic, individuals have postponed or avoided seeking medical attention for non-urgent health issues, including sleep-related disorders. This delay in diagnosis and treatment could impact the demand for sleep apnea devices, as patients not have been identified and prescribed appropriate therapies during the height of the pandemic. The pandemic has accelerated the adoption of telemedicine and remote monitoring solutions across various healthcare sectors. Sleep apnea patients, in particular, have sought virtual consultations and remote monitoring options to avoid in-person visits to healthcare facilities.

This trend could influence the development and adoption of sleep apnea devices with enhanced connectivity features. Economic challenges resulting from the pandemic have affected individuals' ability to afford healthcare services and devices. This economic impact could influence the purchasing decisions of sleep apnea patients, potentially leading to shifts in demand for different types of devices or preferences for more cost-effective solutions. The heightened awareness of respiratory health during the COVID-19 pandemic has increased attention to sleep-related breathing disorders. Healthcare providers and patients alike are more attuned to symptoms of sleep apnea, potentially driving increased diagnoses and treatment once healthcare services returned to a more normalized state. With the widespread adoption of remote work during the pandemic, changes in work schedules and lifestyles have influenced sleep patterns. These shifts could impact the prevalence of sleep disorders, including sleep apnea, and subsequently, the demand for diagnostic and therapeutic devices.

Competitive Landscape

The key players are constantly focusing on innovative product development strategies to gain a competitive edge and expand their business footprints. The companies are devising merger & acquisitions and partnership strategies to expand their product offering and serve the growing customer pool. For instance, in February 2021, Nyxoah SA and Vanderbilt University entered a strategic partnership to develop innovative neurostimulation solutions for treating OSA. Prominent companies in this market include well-established, financially stable manufacturers of diagnostic and therapeutic sleep apnea devices.

These sleep apnea companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent sleep apnea companies in this market include ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).

Key Developments

• In November 2022, ResMed and Alphabet's life science offshoot Verily announced the formation of Primasun, an end-to-end solution to help employers and healthcare providers identify populations at risk for complex sleep disorders.
• In October 2022, Airway Management, manufacturer of the most globally researched custom oral appliances, announced the launch of flexTAP, a premium lab-made oral appliance designed to treat patients with snoring and mild to moderate obstructive sleep apnea.
• In September 2022, GE Healthcare and Wayra teamed up with seven health tech start-ups to accelerate the digital transformation of healthcare across Europe, the Middle East, and Africa.
• In February 2022, the TCM5 Flex Transcutaneous Monitor has been added to Compumedics' already comprehensive line of sleep diagnostic products due to collaboration with Radiometer Pacific. Compumedics is now the TCM 5 Flex's authorized distributor in Australia and New Zealand.
• In 2022, Fisher & Paykel Healthcare (New Zealand) launched Evora Full, a compact full-face mask for obstructive sleep apnea (OSA) treatment in US.

Considered in this report:

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Global Sleep Apnea Devices market with its value and forecast along with its segments
• Region & Country-wise Sleep Apnea Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions & Countries covered in the report

• North America (United States, Canada, Mexico)
• Europe (Germany, United Kingdom, France, Spain, Italy, Russia)
• Asia-Pacific (China, Japan, India, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle-East & Africa (UAE, Saudi Arabia, South Africa)

By Product:

• Positive Airway Pressure (PAP) Devices
• Adaptive Servo-Ventilation (ASV)
• Airway Clearance Systems
• Oxygen Delivery Products
• Oral Appliances
• Others

By End User:

• Home care Settings & Individuals
• Sleep laboratories & Hospitals

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Sleep Apnea Therapeutic Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

""
"
***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.


This product will be delivered within 2 business days.